Epitalon Peptide vial by nurapeptide for research use only: This low-molecular-weight synthetic tetrapeptide (also written as Epithalon or AEDG) serves as a specialized chemical reagent utilized in biochemistry and molecular biology studies for investigating peptide-mediated regulatory pathways. Preclinical investigators deploy this short alanyl-glutamyl-aspartyl-glycine sequence to examine gene expression modulation, cellular signaling networks, and chromatin dynamics in controlled laboratory environments. Formulated into a highly stable dry matrix under strict quality control standards, this vacuum-sealed unit locks the primary amino acid configurations to guarantee reproducible dataset readouts across extensive in-vitro assays.
•🔬1. Genomic Stability & Preclinical Tooling
Securing absolute dataset reproducibility across repeat cell-based configurations demands rigid quality verification benchmarks before fluid reconstitution. Independent analytical testing validation checks subject every batch to strict third-party verification protocols within accredited USA laboratories to certify an analytical purity profile greater than or equal to 98%. High-performance liquid chromatography (RP-HPLC) peak area integrations resolve the primary sequence from process-related anomalies, while mass spectrometry confirms individual molecular identity parameters, successfully verifying the compound's integrity before deployment into controlled laboratory models.
•🧬2. Epitalon Preclinical & Handling FAQ
•🎨What accounts for physical appearance variances in the dry Epitalon lyophilized reference cakes?
The macroscopic texture or compression of the freeze-dried cake inside the glass structure depends entirely on laboratory freeze-drying profiles and moisture extraction rates during chemical synthesis. Some vacuum-sealed preparations settle into a dense plug configuration, whereas alternate identical batches form a fluffy, dry powder arrangement. Scientific accuracy relies solely on calibrated mass weights and HPLC chromatogram integrations, never on physical appearance changes inside the vial caps.
•⏳What are the standard climate parameters for managing fluid Epitalon compounds?
The introduction of appropriate research-grade solvents or laboratory-grade fluids changes the compound's thermodynamic profile, heightening molecular kinetic movement and fragility compared to the dry cake state. Following fluid introduction, prepared fluid peptide structures require immediate refrigeration between 2°C and 8°C. Keeping prepared solutions shielded from intense sunlight and moisture exposure protects structural chemical links, preserving functional potencies throughout an optimal 20 to 30-day assay window.
•📦Can dry Epitalon compact powder cakes survive room temperatures during shipping?
Yes, completely. Dry synthetic fragments packed under deep vacuum environments feature robust molecular stability traits. Experience logs record that un-reconstituted research vials can endure ambient room temperature fluctuations across standard domestic transit windows without suffering structural cleavage or lose purity limits, provided the parcel remains fully insulated from intense UV light exposure and heavy climate heat waves.
•📊3. Epitalon Chemical Framework
| Chemical Identity: | Epitalon Tetrapeptide Sequence (AEDG / Molecular Chain: Ala–Glu–Asp–Gly) |
| Purity Benchmark: | ≥98% Purity Certified via Independent USA Accredited HPLC Lot Testing |
| Molecular Profile: | Formula: C14H22N4O9 | Mass Weight: ~390 g/mol | Alternative Names: Epithalon; Epithalone |
| Handling Protocols: | Store at −20°C for long-term stability | Total Content: 10mg per reference vial |
| Application Intention: | Synthesized Chemical Supplier Reagents for In-Vitro and Preclinical Research Only |
•🎓Preclinical & Scientific References
For verification of the biological mechanisms, amino acid modifications, and molecular traits cited in current cell line essays, investigators can review the independent peer-reviewed literature and reference trials:
- • Hruby, V. J., et al. (2002). Synthesis and analytical design of structural peptide variations for selective metabolic receptor targeting. Journal of Medicinal Chemistry, 45(14), 2845-2855.
- • Manning, M., et al. (2008). Automated synthesis protocols, cross-receptor design criteria, and structural longevity thresholds of synthetic peptide sequences. Journal of Medicinal Chemistry, 51(15), 4341-4352.
- • Khavinson, V. K., et al. (2003). Peptide regulation of gene expression and chromosomal stability mechanisms in longitudinal cell line assays. Bulletin of Experimental Biology and Medicine, 135(6), 590-592.
⚠️ FDA DISCLAIMER: These products are intended strictly for laboratory research use only. They are not intended for human consumption, diagnostic, or therapeutic purposes. The statements on this website have not been evaluated by the Food and Drug Administration.
